Disclosures for "Efficacy and Safety of Efgartigimod in the Treatment of Amyotrophic Lateral Sclerosis (ALS): A Retrospective Cohort Study"
-
Prof. YAO has nothing to disclose.
-
Dr. XIE has nothing to disclose.
-
Dr. Huang has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Ms. Zhong has nothing to disclose.
-
Miss Wang has nothing to disclose.